Senior Director, Analytical Sciences, Bicycle Therapeutics

Dr Feilden joined Bicycle in October 2022 where he leads the CMC analytical science team.  He has over 25 years' experience in the pharmaceutical industry having worked for both CROs and large pharma.  His area of work has been around trace analysis and he is an expert in extractables and leachables.  He completed his degree and DPhil at the University of York.